Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Scatton

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2001
The preclinical pharmacologic profile of tiaprideB Scatton, C Cohen, G Perrault, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case reportS Pappata, P Cornu, Y Samson, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1989
Critical review on quantitative autoradiography of D1 and D2 dopaminergic receptors in the striatum of the mammalian brain: differential localization and plastic changes after pharmacological manipulation and dopaminergic input disruptionC Feuerstein, R Peretti-Renucci, M Savasta, et al.
Brain Research|July 9, 1990
The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegenerationJ Benavides, C Capdeville, F Dauphin, et al.
Journal of Affective Disorders|May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitorO Curet, G Damoiseau-Ovens, C Sauvage, et al.
Molecular Pharmacology|June 1, 1995
Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoinP Granger, B Biton, C Faure, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.
Neuroscience|January 1, 1989
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortexF Javoy-Agid, B Scatton, M Ruberg, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2001
The preclinical pharmacologic profile of tiaprideB Scatton, C Cohen, G Perrault, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1991
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case reportS Pappata, P Cornu, Y Samson, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|June 1, 1989
Critical review on quantitative autoradiography of D1 and D2 dopaminergic receptors in the striatum of the mammalian brain: differential localization and plastic changes after pharmacological manipulation and dopaminergic input disruptionC Feuerstein, R Peretti-Renucci, M Savasta, et al.
Brain Research|July 9, 1990
The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegenerationJ Benavides, C Capdeville, F Dauphin, et al.
Journal of Affective Disorders|May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitorO Curet, G Damoiseau-Ovens, C Sauvage, et al.
Molecular Pharmacology|June 1, 1995
Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoinP Granger, B Biton, C Faure, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.
Neuroscience|January 1, 1989
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortexF Javoy-Agid, B Scatton, M Ruberg, et al.
Pageof 26